Remove Development Remove Efficiency Remove Pharmaceuticals Remove Recruiting
article thumbnail

This Pharma Company Stays Innovative by Doing Two Things

Harvard Business

When one of us (Vivek) and his team launched Roivant Sciences in 2014 and began developing treatments for Alzheimer’s disease — they were determined to learn from the pharma industry’s innovation issues and build a more sustainable innovation engine. Roivant’s first response was to address misaligned incentives.

Company 33
article thumbnail

Is M&A the Cure for a Failing Health Care System?

Harvard Business

Is free-market magic finally bringing Amazon-style convenience, quality, and efficiency to health care? To become a Geisinger or an Intermountain equivalent, Aetna-CVS would have to acquire — or develop — seamless relationships with legions of primary care and specialty physicians and hospitals. Could this be it?

System 28
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Changing Company Culture Requires a Movement, Not a Mandate

Harvard Business

Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency. Prasad, CEO of Dr. Reddy’s, a 33-year-old global pharmaceutical company headquartered in India that produces affordable generic medication.

Culture 53
article thumbnail

Change Management Is Becoming Increasingly Data-Driven. Companies Aren’t Ready

Harvard Business

At EY, where some of us work, we have developed a tool for social media analytics called SMAART that is able to understand sentiment within consumer and influencer groups. Organizations often seem obsessed by measuring fractional shifts in operational performance, capturing data on sales, inventory turns, and manufacturing efficiency.

article thumbnail

The Promise and Challenge of Big Data for Pharma

Harvard Business

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development.

Data 28
article thumbnail

PricewaterhouseCoopers, LLP

Management Consulted

PwC moved on to acquire Ant’s Eye View, in August 2012, a social media strategy development and consulting firm. Helps federal agencies solve complex business issues, manage risk, and improve financial measures and the overall quality, efficiency and effectiveness of public service. Pharmaceuticals & Life Science.

article thumbnail

The Crazy Lives of Consultants: is it just me.

The Crazy Lives of Consultants

Girls who are hospitable and who have flair to serve people with the best fun services have been recruited by the New York escort agencies thus satiating every pleasure need of clients. It was previously sold as Fastin from King Pharmaceuticals for SmithKline Beecham, however in 1998 it was removed from the market. Anonymous said.